GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Organics Ltd (NSE:MEDIORG) » Definitions » Beneish M-Score

Medicamen Organics (NSE:MEDIORG) Beneish M-Score : -1.43 (As of Dec. 12, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Medicamen Organics Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.43 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Medicamen Organics's Beneish M-Score or its related term are showing as below:

NSE:MEDIORG' s Beneish M-Score Range Over the Past 10 Years
Min: -1.75   Med: -1.59   Max: -1.43
Current: -1.43

During the past 4 years, the highest Beneish M-Score of Medicamen Organics was -1.43. The lowest was -1.75. And the median was -1.59.


Medicamen Organics Beneish M-Score Historical Data

The historical data trend for Medicamen Organics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Organics Beneish M-Score Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Beneish M-Score
- - -1.75 -1.43

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24
Beneish M-Score - - -1.75 - -1.43

Competitive Comparison of Medicamen Organics's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Organics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicamen Organics's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicamen Organics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medicamen Organics's Beneish M-Score falls into.



Medicamen Organics Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medicamen Organics for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3591+0.528 * 0.7649+0.404 * 0.7662+0.892 * 1.1411+0.115 * 0.9581
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8617+4.679 * 0.157918-0.327 * 0.8361
=-1.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₹167.0 Mil.
Revenue was ₹252.7 Mil.
Gross Profit was ₹94.7 Mil.
Total Current Assets was ₹273.1 Mil.
Total Assets was ₹385.8 Mil.
Property, Plant and Equipment(Net PPE) was ₹104.9 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹7.2 Mil.
Selling, General, & Admin. Expense(SGA) was ₹12.4 Mil.
Total Current Liabilities was ₹218.4 Mil.
Long-Term Debt & Capital Lease Obligation was ₹1.6 Mil.
Net Income was ₹24.0 Mil.
Gross Profit was ₹0.0 Mil.
Cash Flow from Operations was ₹-36.9 Mil.
Total Receivables was ₹107.7 Mil.
Revenue was ₹221.5 Mil.
Gross Profit was ₹63.5 Mil.
Total Current Assets was ₹208.7 Mil.
Total Assets was ₹325.9 Mil.
Property, Plant and Equipment(Net PPE) was ₹108.6 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹7.1 Mil.
Selling, General, & Admin. Expense(SGA) was ₹12.6 Mil.
Total Current Liabilities was ₹219.0 Mil.
Long-Term Debt & Capital Lease Obligation was ₹3.3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(167 / 252.717) / (107.682 / 221.471)
=0.660818 / 0.486213
=1.3591

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(63.499 / 221.471) / (94.731 / 252.717)
=0.286715 / 0.37485
=0.7649

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (273.122 + 104.854) / 385.807) / (1 - (208.659 + 108.565) / 325.857)
=0.020298 / 0.026493
=0.7662

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=252.717 / 221.471
=1.1411

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(7.116 / (7.116 + 108.565)) / (7.194 / (7.194 + 104.854))
=0.061514 / 0.064205
=0.9581

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(12.354 / 252.717) / (12.565 / 221.471)
=0.048885 / 0.056734
=0.8617

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.614 + 218.352) / 385.807) / ((3.263 + 218.954) / 325.857)
=0.570145 / 0.681946
=0.8361

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(24.041 - 0 - -36.885) / 385.807
=0.157918

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medicamen Organics has a M-score of -1.43 signals that the company is likely to be a manipulator.


Medicamen Organics Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Medicamen Organics's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicamen Organics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd is engaged in developing, manufacturing, and distribution of broad range of pharmaceutical dosages including generic dosages in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government and private institutions as contract manufacturer/third party manufacturer. The company markets its product to private pharma companies in domestic as well as international markets through third-party distributors or on a loan license basis.

Medicamen Organics Headlines

No Headlines